BOSTON--(BUSINESS WIRE)--Aris Global, a leading provider of software solutions for the life sciences industry, today announced that Novo Nordisk, a world leader in diabetes care, implemented Register™ as their standard for regulatory information management, providing a global and uniform process for determining regulatory action and status. Register is a Web-based regulatory solution that offers a central repository for managing the end-to-end tracking of product registration details and submissions.
